![Ekambar R. Kandimalla](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ekambar R. Kandimalla
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Ekambar R. Kandimalla
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ekambar R. Kandimalla
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
MOLOGEN AG | Miscellaneous Commercial Services | Chief Executive Officer | |
Freie Universität Berlin | College/University | Doctorate Degree | |
Verband Forschender Arzneimittelhersteller eV
![]() Verband Forschender Arzneimittelhersteller eV Miscellaneous Commercial ServicesCommercial Services Verband Forschender Arzneimittelhersteller eV, founded in 1994, is an association of researching pharmaceutical companies in Germany. The private company is based in Berlin, Germany. The German company's main focus is on the drugs and therapies currently being researched in the industry. | Miscellaneous Commercial Services | Director/Board Member | |
Vaximm AG
![]() Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Chief Executive Officer | |
Exicure Operating Co.
![]() Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Pharmaceuticals: Major | Chief Operating Officer | |
University of Hannover | College/University | Undergraduate Degree | |
Inceptor Bio LLC
![]() Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | Biotechnology | Chief Executive Officer | |
Takeda Pharmaceuticals U.S.A., Inc.
![]() Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Corporate Officer/Principal | |
San Francisco State University | College/University | Undergraduate Degree | |
Queen's University | College/University | Graduate Degree |
Statistik
International
Deutschland | 5 |
Vereinigte Staaten | 5 |
Schweiz | 2 |
Kanada | 2 |
Sektoral
Consumer Services | 5 |
Commercial Services | 4 |
Health Technology | 4 |
Operativ
Chief Executive Officer | 4 |
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Chief Operating Officer | 2 |
Undergraduate Degree | 2 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Matthias Schroff | 8 |
Jocelyn Trokenheim | 4 |
- Börse
- Insiders
- Ekambar R. Kandimalla
- Unternehmensverbindungen